Drugs / p53 peptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001827 | Jul 1999 → Dec 2007 | ovarian neoplasm | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | p53 peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001827 ↗ |
| Modality | Vaccine | “vaccination with a p53 peptide” NCT00001827 ↗ |
| Route | Subcutaneous | “injected under the skin” NCT00001827 ↗ |